title: Optimisation of polyethylenimine-based gene delivery to mouse brain.
abstract: Polyethylenimine (PEI) is proving to be an efficient and versatile vector for gene delivery in vivo. However, a limiting factor is the relatively short duration of gene expression in some sites. Given the particularly high levels of expression seen in the short term we postulated that loss of expression could result from overloading the nucleus with foreign DNA. To address this problem we first followed DNA delivery and localisation with digoxin-labelled plasmid DNA complexed with 22 kD linear PEI and used these complexes for intraventricular injection into brains of anaesthetised newborn mice. At 24 h post-injection, labelled DNA was found exclusively in the nuclear and perinuclear regions. We next carried out a dose response curve using decreasing amounts of DNA, either in a constant volume (2 microl) or at a constant concentration (500 ng/microl). In both conditions, transgene expression yield was maximum at 100 ng DNA per injection. Using this optimal amount of DNA increased yield of transgene expression significantly at 24 h and one week post-injection as compared to 1 microg DNA. A final point addressed was whether co-expressing an anti-apoptotic gene could enhance gene expression in the longer term. Co-expressing bcl-X(L) with luciferase or LacZ significantly increased expression of both these genes at one week post-injection.
authors.affiliation: Laboratoire de Physiologie Générale et Comparée, UMR CNRS 8572, Muséum National d'Histoire Naturelle, Paris, France.
authors.forename: G F
authors.initials: GF
authors.lastname: Lemkine
authors.forename: D
authors.initials: D
authors.lastname: Goula
authors.forename: N
authors.initials: N
authors.lastname: Becker
authors.forename: L
authors.initials: L
authors.lastname: Paleari
authors.forename: G
authors.initials: G
authors.lastname: Levi
authors.forename: B A
authors.initials: BA
authors.lastname: Demeneix
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D017209:Apoptosis / Q000235:genetics; D001921:Brain / Q000378:metabolism*; D004247:DNA / Q000378:metabolism*; D004077:Digoxin / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000235:genetics*; D066298:In Vitro Techniques; D007276:Injections, Intraventricular; D008156:Luciferases / Q000378:metabolism*; D051379:Mice; D010957:Plasmids / Q000737:chemistry; D011094:Polyethyleneimine / Q000493:pharmacokinetics*; D013997:Time Factors
chemical_list: D004077:Digoxin; D011094:Polyethyleneimine; D004247:DNA; D008156:Luciferases